Spero Therapeutics Delivers On Game Plan To Create Shareholder Value

3d ago, source:

Spero has excellent downside protection and additional upside from the payments from the Tebipenem HBr deal with GSK. Learn ...

The Volatility of Spero Therapeutics Inc’s (SPRO) Stock: A 0.91% Ratio for the Week

14d ago, source: newsheater

The stock of Spero Therapeutics Inc (SPRO) has gone up by 0.91% for the week, with a 0.30% rise in the past month and a 14.04% rise in the past quarter. The volatility ratio for the week is 4.69%, and ...

Analysts Update Their Estimates For Spero Therapeutics Inc

14d ago, source:

Spero Therapeutics Inc (NASDAQ:SPRO) concluded the trading at $1.64 on Friday, April 12 with a fall of -4.09% from its closing price on previous day. Taking a look at stock we notice that its last ...

GSK announces positive results from pivotal EAGLE-1 phase III trial of gepotidacin for uncomplicated urogenital gonorrhoea

8d ago, source: Pharmabiz

GSK plc announced positive results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action for uncomplicated urogenital ...

14 Cheap Penny Stocks to Buy According to Analysts

10d ago, source: InvestingChannel on MSN

In this article, we will take a detailed look at the 14 Cheap Penny Stocks to Buy According to Analysts. For a quick overview ...

News - Ferring Pharmaceuticals

8mon ago, source: The Pharma Letter

Privately-held Swiss drugmaker Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome have announced a research and development collaboration to drive forward new ...